Share Price and Basic Stock Data
Last Updated: November 26, 2025, 4:18 pm
| PEG Ratio | 10.62 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Colgate-Palmolive (India) Ltd, a leader in the personal care sector, reported a market capitalization of ₹59,483 Cr and a share price of ₹2,187. The company has consistently demonstrated a robust revenue trajectory, with sales recorded at ₹5,226 Cr for the fiscal year ending March 2023. This figure is projected to rise to ₹6,040 Cr by March 2025. The quarterly sales data indicates a steady increase, with the most recent quarter (September 2023) achieving ₹1,471 Cr, up from ₹1,324 Cr in June 2023. This upward trend underscores Colgate’s ability to maintain consumer demand amidst competitive pressures. The operating profit margin (OPM) stood at 32%, reflecting strong operational efficiency. The company’s financial strength is further highlighted by a return on equity (ROE) of 81.2% and return on capital employed (ROCE) of 105%, which are significantly higher than typical sector averages, indicating effective capital utilization and profitability management.
Profitability and Efficiency Metrics
Colgate-Palmolive (India) Ltd reported impressive profitability metrics with a net profit of ₹1,326 Cr for the fiscal year ending March 2025, showcasing an increase from ₹1,324 Cr in the previous fiscal year. The company’s net profit margin improved to 23.78%, indicating effective cost management strategies. The operating profit for the same period rose to ₹1,958 Cr, affirming the company’s robust operational capabilities. Additionally, the interest coverage ratio (ICR) stood at an extraordinary 485.39x, showcasing the company’s ability to comfortably meet its interest obligations. The cash conversion cycle (CCC) recorded a negative figure of -95 days, which suggests efficient inventory and receivables management, allowing the company to convert its investments back into cash swiftly. These metrics position Colgate as a financially sound entity, capable of delivering consistent returns to its shareholders while navigating the complexities of the personal care market.
Balance Sheet Strength and Financial Ratios
Colgate-Palmolive (India) Ltd maintains a strong balance sheet characterized by total assets of ₹3,019 Cr and total liabilities of ₹3,019 Cr as of March 2025. The company holds reserves of ₹1,555 Cr and minimal borrowings of ₹60 Cr, reflecting a conservative approach to debt and strong capital reserves. The price-to-book value (P/BV) ratio is reported at 39.07x, indicating a premium valuation relative to its book value, which stood at ₹61.19 per share. Additionally, the current ratio of 1.38 and quick ratio of 1.08 demonstrate adequate liquidity, ensuring the company can cover its short-term liabilities comfortably. The dividend payout ratio is notably high at 113.57%, reflecting a commitment to returning value to shareholders. However, this high payout could potentially limit reinvestment opportunities for future growth, which is a critical factor for investors to consider.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Colgate-Palmolive (India) Ltd reveals a stable structure, with promoters holding 51% of the company. Foreign institutional investors (FIIs) accounted for 17.16% of the shareholding, having seen a decline from 24.94% in September 2024. Domestic institutional investors (DIIs) increased their stake to 11.95%, indicating growing confidence among domestic investors. The public holding stands at 19.59%, with the total number of shareholders reaching 3,32,409. This diversified ownership structure enhances corporate governance and aligns the interests of various stakeholders. Notably, the consistent promoter holding signals stability and a long-term commitment to the company’s growth. However, the decline in FII participation could raise concerns regarding international investor sentiment towards the stock, especially in a competitive market environment.
Outlook, Risks, and Final Insight
Looking ahead, Colgate-Palmolive (India) Ltd is well-positioned to leverage its strong brand equity and operational efficiency to capitalize on growth opportunities in the personal care industry. However, potential risks include increased competition from both domestic and international players, which could pressure market share and pricing strategies. Additionally, fluctuations in raw material costs could impact profit margins. The company’s high dividend payout ratio raises questions about its future reinvestment capabilities, which could affect long-term growth prospects. Should the company maintain its current performance levels and manage external pressures effectively, it may continue to deliver strong returns. Conversely, any significant shift in market dynamics could necessitate strategic adjustments to maintain its competitive edge. Overall, the firm’s fundamentals suggest a resilient outlook, albeit with some caution warranted regarding the evolving market landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Colgate-Palmolive (India) Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Honasa Consumer Ltd | 9,558 Cr. | 294 | 334/190 | 76.8 | 38.8 | 0.00 % | 7.44 % | 5.51 % | 10.0 |
| Ambica Agarbathies Aroma & Industries Ltd | 43.9 Cr. | 25.6 | 37.0/23.3 | 86.2 | 65.2 | 0.00 % | 7.49 % | 0.45 % | 10.0 |
| Ador Multi Products Ltd | 105 Cr. | 110 | 119/23.4 | 32.5 | 0.00 % | 11.4 % | 3.09 % | 10.0 | |
| Kaya Ltd | 614 Cr. | 405 | 488/204 | 60.9 | 0.00 % | 2.50 % | % | 10.0 | |
| Jyothy Labs Ltd | 11,358 Cr. | 309 | 433/268 | 31.0 | 55.8 | 1.14 % | 24.6 % | 19.0 % | 1.00 |
| Industry Average | 71,436.57 Cr | 1,925.31 | 56.60 | 112.56 | 0.74% | 29.21% | 23.91% | 4.94 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,197 | 1,387 | 1,291 | 1,351 | 1,324 | 1,471 | 1,396 | 1,490 | 1,497 | 1,619 | 1,462 | 1,463 | 1,434 |
| Expenses | 871 | 979 | 930 | 899 | 906 | 989 | 927 | 958 | 988 | 1,122 | 1,007 | 964 | 981 |
| Operating Profit | 326 | 408 | 361 | 452 | 418 | 482 | 468 | 532 | 508 | 497 | 454 | 498 | 453 |
| OPM % | 27% | 29% | 28% | 33% | 32% | 33% | 34% | 36% | 34% | 31% | 31% | 34% | 32% |
| Other Income | 2 | 11 | 10 | 18 | -5 | 21 | 18 | 23 | 23 | 76 | 20 | 19 | 18 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 44 | 44 | 44 | 43 | 44 | 44 | 41 | 42 | 42 | 42 | 41 | 38 | 38 |
| Profit before tax | 282 | 374 | 327 | 426 | 369 | 458 | 443 | 511 | 489 | 530 | 433 | 478 | 432 |
| Tax % | 26% | 26% | 26% | 26% | 26% | 26% | 26% | 26% | 26% | 26% | 25% | 26% | 26% |
| Net Profit | 210 | 278 | 243 | 316 | 274 | 340 | 330 | 380 | 364 | 395 | 323 | 355 | 321 |
| EPS in Rs | 7.71 | 10.22 | 8.94 | 11.63 | 10.06 | 12.50 | 12.14 | 13.96 | 13.38 | 14.52 | 11.87 | 13.05 | 11.79 |
Last Updated: August 2, 2025, 1:15 am
Below is a detailed analysis of the quarterly data for Colgate-Palmolive (India) Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 1,434.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,463.00 Cr. (Mar 2025) to 1,434.00 Cr., marking a decrease of 29.00 Cr..
- For Expenses, as of Jun 2025, the value is 981.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 964.00 Cr. (Mar 2025) to 981.00 Cr., marking an increase of 17.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 453.00 Cr.. The value appears to be declining and may need further review. It has decreased from 498.00 Cr. (Mar 2025) to 453.00 Cr., marking a decrease of 45.00 Cr..
- For OPM %, as of Jun 2025, the value is 32.00%. The value appears to be declining and may need further review. It has decreased from 34.00% (Mar 2025) to 32.00%, marking a decrease of 2.00%.
- For Other Income, as of Jun 2025, the value is 18.00 Cr.. The value appears to be declining and may need further review. It has decreased from 19.00 Cr. (Mar 2025) to 18.00 Cr., marking a decrease of 1.00 Cr..
- For Interest, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 38.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 38.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 432.00 Cr.. The value appears to be declining and may need further review. It has decreased from 478.00 Cr. (Mar 2025) to 432.00 Cr., marking a decrease of 46.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 26.00%.
- For Net Profit, as of Jun 2025, the value is 321.00 Cr.. The value appears to be declining and may need further review. It has decreased from 355.00 Cr. (Mar 2025) to 321.00 Cr., marking a decrease of 34.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 11.79. The value appears to be declining and may need further review. It has decreased from 13.05 (Mar 2025) to 11.79, marking a decrease of 1.26.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 5:53 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,579 | 3,982 | 3,868 | 3,982 | 4,188 | 4,462 | 4,525 | 4,841 | 5,100 | 5,226 | 5,680 | 6,040 | 5,878 |
| Expenses | 2,915 | 3,159 | 2,929 | 3,038 | 3,074 | 3,226 | 3,323 | 3,331 | 3,534 | 3,679 | 3,779 | 4,082 | 4,008 |
| Operating Profit | 664 | 823 | 940 | 944 | 1,114 | 1,236 | 1,202 | 1,510 | 1,566 | 1,547 | 1,901 | 1,958 | 1,870 |
| OPM % | 19% | 21% | 24% | 24% | 27% | 28% | 27% | 31% | 31% | 30% | 33% | 32% | 32% |
| Other Income | 115 | 32 | 7 | 41 | 26 | 68 | 49 | 30 | 26 | 42 | 57 | 139 | 72 |
| Interest | 0 | 0 | 0 | 0 | 0 | 2 | 10 | 7 | 6 | 5 | 5 | 4 | 4 |
| Depreciation | 51 | 75 | 111 | 133 | 157 | 159 | 198 | 182 | 177 | 175 | 172 | 163 | 154 |
| Profit before tax | 728 | 780 | 835 | 851 | 983 | 1,143 | 1,043 | 1,350 | 1,409 | 1,410 | 1,781 | 1,930 | 1,784 |
| Tax % | 26% | 28% | 30% | 32% | 32% | 32% | 22% | 23% | 23% | 26% | 26% | 26% | |
| Net Profit | 540 | 559 | 581 | 577 | 673 | 776 | 816 | 1,035 | 1,078 | 1,047 | 1,324 | 1,437 | 1,326 |
| EPS in Rs | 19.85 | 20.55 | 21.37 | 21.23 | 24.76 | 28.52 | 30.02 | 38.07 | 39.65 | 38.50 | 48.67 | 52.83 | 48.75 |
| Dividend Payout % | 68% | 58% | 47% | 47% | 97% | 81% | 93% | 100% | 101% | 101% | 119% | 97% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 3.52% | 3.94% | -0.69% | 16.64% | 15.30% | 5.15% | 26.84% | 4.15% | -2.88% | 26.46% | 8.53% |
| Change in YoY Net Profit Growth (%) | 0.00% | 0.42% | -4.62% | 17.33% | -1.33% | -10.15% | 21.68% | -22.68% | -7.03% | 29.33% | -17.92% |
Colgate-Palmolive (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 6% |
| 3 Years: | 6% |
| TTM: | 2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 12% |
| 3 Years: | 10% |
| TTM: | -1% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 13% |
| 3 Years: | 14% |
| 1 Year: | -33% |
| Return on Equity | |
|---|---|
| 10 Years: | 64% |
| 5 Years: | 73% |
| 3 Years: | 72% |
| Last Year: | 81% |
Last Updated: September 4, 2025, 9:30 pm
Balance Sheet
Last Updated: November 9, 2025, 1:31 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14 | 14 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 |
| Reserves | 586 | 757 | 1,004 | 1,247 | 1,497 | 1,420 | 1,567 | 1,139 | 1,707 | 1,689 | 1,847 | 1,637 | 1,555 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 83 | 102 | 91 | 83 | 69 | 72 | 61 | 60 |
| Other Liabilities | 894 | 932 | 972 | 1,037 | 1,039 | 1,097 | 908 | 1,637 | 1,084 | 1,098 | 1,250 | 1,293 | 1,535 |
| Total Liabilities | 1,493 | 1,702 | 2,003 | 2,311 | 2,564 | 2,626 | 2,604 | 2,894 | 2,902 | 2,883 | 3,197 | 3,019 | 3,178 |
| Fixed Assets | 556 | 782 | 1,008 | 1,108 | 1,146 | 1,191 | 1,123 | 1,065 | 963 | 862 | 794 | 776 | 742 |
| CWIP | 142 | 141 | 78 | 167 | 159 | 199 | 190 | 145 | 122 | 114 | 110 | 38 | 29 |
| Investments | 37 | 37 | 31 | 31 | 31 | 31 | 19 | 19 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 759 | 742 | 885 | 1,005 | 1,228 | 1,206 | 1,272 | 1,666 | 1,817 | 1,907 | 2,292 | 2,204 | 2,406 |
| Total Assets | 1,493 | 1,702 | 2,003 | 2,311 | 2,564 | 2,626 | 2,604 | 2,894 | 2,902 | 2,883 | 3,197 | 3,019 | 3,178 |
Below is a detailed analysis of the balance sheet data for Colgate-Palmolive (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 27.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 27.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,555.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,637.00 Cr. (Mar 2025) to 1,555.00 Cr., marking a decrease of 82.00 Cr..
- For Borrowings, as of Sep 2025, the value is 60.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 61.00 Cr. (Mar 2025) to 60.00 Cr., marking a decrease of 1.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1,535.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,293.00 Cr. (Mar 2025) to 1,535.00 Cr., marking an increase of 242.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 3,178.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,019.00 Cr. (Mar 2025) to 3,178.00 Cr., marking an increase of 159.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 742.00 Cr.. The value appears to be declining and may need further review. It has decreased from 776.00 Cr. (Mar 2025) to 742.00 Cr., marking a decrease of 34.00 Cr..
- For CWIP, as of Sep 2025, the value is 29.00 Cr.. The value appears to be declining and may need further review. It has decreased from 38.00 Cr. (Mar 2025) to 29.00 Cr., marking a decrease of 9.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 2,406.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,204.00 Cr. (Mar 2025) to 2,406.00 Cr., marking an increase of 202.00 Cr..
- For Total Assets, as of Sep 2025, the value is 3,178.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,019.00 Cr. (Mar 2025) to 3,178.00 Cr., marking an increase of 159.00 Cr..
Notably, the Reserves (1,555.00 Cr.) exceed the Borrowings (60.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 664.00 | 823.00 | 940.00 | 944.00 | 1.00 | -82.00 | -101.00 | -90.00 | -82.00 | -68.00 | -71.00 | -60.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 6 | 6 | 10 | 12 | 18 | 17 | 11 | 9 | 16 | 11 | 11 | 14 |
| Inventory Days | 59 | 63 | 72 | 72 | 56 | 58 | 69 | 79 | 78 | 68 | 63 | 76 |
| Days Payable | 130 | 128 | 136 | 148 | 152 | 144 | 142 | 179 | 169 | 155 | 187 | 185 |
| Cash Conversion Cycle | -65 | -59 | -55 | -63 | -79 | -68 | -63 | -91 | -75 | -76 | -113 | -95 |
| Working Capital Days | -47 | -40 | -43 | -39 | -33 | -36 | -23 | -84 | -25 | -32 | -46 | -37 |
| ROCE % | 122% | 114% | 96% | 74% | 71% | 73% | 65% | 92% | 92% | 79% | 97% | 105% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Nippon India Multi Cap Fund | 500,473 | 0.49 | 135.65 | 500,473 | 2025-04-22 17:25:44 | 0% |
| Nippon India Large Cap Fund | 497,594 | 0.55 | 134.87 | 497,594 | 2025-04-22 13:03:42 | 0% |
| Franklin India Prima Fund | 450,000 | 1.21 | 121.97 | 450,000 | 2025-04-22 17:25:44 | 0% |
| NJ Balanced Advantage Fund | 345,381 | 2.36 | 93.61 | 345,381 | 2025-04-22 17:25:44 | 0% |
| Nippon India ETF Nifty Next 50 Junior BeES | 341,321 | 1.98 | 92.51 | 341,321 | 2025-04-22 17:25:44 | 0% |
| NJ Flexi Cap Fund | 187,246 | 4.68 | 50.75 | 187,246 | 2025-04-22 17:25:44 | 0% |
| Franklin India Equity Advantage Fund | 169,458 | 1.46 | 45.93 | 169,458 | 2025-04-22 17:25:44 | 0% |
| Axis Growth Opportunities Fund | 123,167 | 0.28 | 33.38 | 123,167 | 2025-04-22 17:25:44 | 0% |
| Baroda BNP Paribas Midcap Fund | 105,000 | 1.59 | 28.46 | 105,000 | 2025-04-22 17:25:44 | 0% |
| Templeton India Equity Income Fund | 100,000 | 1.31 | 27.1 | 100,000 | 2025-04-22 17:25:44 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 52.83 | 48.67 | 38.50 | 39.65 | 38.07 |
| Diluted EPS (Rs.) | 52.83 | 48.67 | 38.50 | 39.65 | 38.07 |
| Cash EPS (Rs.) | 58.81 | 54.97 | 44.93 | 46.16 | 44.78 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 61.19 | 68.91 | 63.11 | 63.78 | 42.86 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 61.19 | 68.91 | 63.11 | 63.78 | 42.86 |
| Dividend / Share (Rs.) | 51.00 | 58.00 | 39.00 | 40.00 | 38.00 |
| Revenue From Operations / Share (Rs.) | 222.07 | 208.85 | 192.15 | 187.50 | 178.00 |
| PBDIT / Share (Rs.) | 77.09 | 72.70 | 58.85 | 58.54 | 56.62 |
| PBIT / Share (Rs.) | 71.11 | 66.39 | 52.42 | 52.02 | 49.91 |
| PBT / Share (Rs.) | 70.95 | 65.49 | 51.83 | 51.80 | 49.64 |
| Net Profit / Share (Rs.) | 52.82 | 48.67 | 38.50 | 39.65 | 38.07 |
| PBDIT Margin (%) | 34.71 | 34.80 | 30.62 | 31.22 | 31.80 |
| PBIT Margin (%) | 32.02 | 31.79 | 27.28 | 27.74 | 28.04 |
| PBT Margin (%) | 31.95 | 31.35 | 26.97 | 27.62 | 27.89 |
| Net Profit Margin (%) | 23.78 | 23.30 | 20.03 | 21.14 | 21.38 |
| Return on Networth / Equity (%) | 86.32 | 70.61 | 61.00 | 62.16 | 88.80 |
| Return on Capital Employeed (%) | 111.06 | 92.26 | 79.28 | 77.76 | 106.38 |
| Return On Assets (%) | 47.59 | 41.40 | 36.32 | 37.15 | 35.77 |
| Asset Turnover Ratio (%) | 1.94 | 1.87 | 1.81 | 1.76 | 1.76 |
| Current Ratio (X) | 1.38 | 1.54 | 1.43 | 1.37 | 0.84 |
| Quick Ratio (X) | 1.08 | 1.30 | 1.12 | 1.04 | 0.64 |
| Inventory Turnover Ratio (X) | 4.69 | 4.61 | 4.31 | 3.95 | 3.95 |
| Dividend Payout Ratio (NP) (%) | 113.57 | 88.35 | 101.29 | 47.92 | 141.85 |
| Dividend Payout Ratio (CP) (%) | 102.02 | 78.22 | 86.80 | 41.15 | 120.59 |
| Earning Retention Ratio (%) | -13.57 | 11.65 | -1.29 | 52.08 | -41.85 |
| Cash Earning Retention Ratio (%) | -2.02 | 21.78 | 13.20 | 58.85 | -20.59 |
| Interest Coverage Ratio (X) | 485.39 | 395.76 | 325.74 | 270.10 | 212.15 |
| Interest Coverage Ratio (Post Tax) (X) | 333.59 | 269.83 | 216.38 | 183.92 | 143.63 |
| Enterprise Value (Cr.) | 63942.79 | 72358.90 | 40063.94 | 41171.93 | 41551.30 |
| EV / Net Operating Revenue (X) | 10.59 | 12.74 | 7.67 | 8.07 | 8.58 |
| EV / EBITDA (X) | 30.49 | 36.59 | 25.03 | 25.86 | 26.98 |
| MarketCap / Net Operating Revenue (X) | 10.77 | 12.98 | 7.84 | 8.22 | 8.76 |
| Retention Ratios (%) | -13.57 | 11.64 | -1.29 | 52.07 | -41.85 |
| Price / BV (X) | 39.07 | 39.34 | 23.88 | 24.17 | 36.38 |
| Price / Net Operating Revenue (X) | 10.77 | 12.98 | 7.84 | 8.22 | 8.76 |
| EarningsYield | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 |
After reviewing the key financial ratios for Colgate-Palmolive (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 52.83. This value is within the healthy range. It has increased from 48.67 (Mar 24) to 52.83, marking an increase of 4.16.
- For Diluted EPS (Rs.), as of Mar 25, the value is 52.83. This value is within the healthy range. It has increased from 48.67 (Mar 24) to 52.83, marking an increase of 4.16.
- For Cash EPS (Rs.), as of Mar 25, the value is 58.81. This value is within the healthy range. It has increased from 54.97 (Mar 24) to 58.81, marking an increase of 3.84.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 61.19. It has decreased from 68.91 (Mar 24) to 61.19, marking a decrease of 7.72.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 61.19. It has decreased from 68.91 (Mar 24) to 61.19, marking a decrease of 7.72.
- For Dividend / Share (Rs.), as of Mar 25, the value is 51.00. This value exceeds the healthy maximum of 3. It has decreased from 58.00 (Mar 24) to 51.00, marking a decrease of 7.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 222.07. It has increased from 208.85 (Mar 24) to 222.07, marking an increase of 13.22.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 77.09. This value is within the healthy range. It has increased from 72.70 (Mar 24) to 77.09, marking an increase of 4.39.
- For PBIT / Share (Rs.), as of Mar 25, the value is 71.11. This value is within the healthy range. It has increased from 66.39 (Mar 24) to 71.11, marking an increase of 4.72.
- For PBT / Share (Rs.), as of Mar 25, the value is 70.95. This value is within the healthy range. It has increased from 65.49 (Mar 24) to 70.95, marking an increase of 5.46.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 52.82. This value is within the healthy range. It has increased from 48.67 (Mar 24) to 52.82, marking an increase of 4.15.
- For PBDIT Margin (%), as of Mar 25, the value is 34.71. This value is within the healthy range. It has decreased from 34.80 (Mar 24) to 34.71, marking a decrease of 0.09.
- For PBIT Margin (%), as of Mar 25, the value is 32.02. This value exceeds the healthy maximum of 20. It has increased from 31.79 (Mar 24) to 32.02, marking an increase of 0.23.
- For PBT Margin (%), as of Mar 25, the value is 31.95. This value is within the healthy range. It has increased from 31.35 (Mar 24) to 31.95, marking an increase of 0.60.
- For Net Profit Margin (%), as of Mar 25, the value is 23.78. This value exceeds the healthy maximum of 10. It has increased from 23.30 (Mar 24) to 23.78, marking an increase of 0.48.
- For Return on Networth / Equity (%), as of Mar 25, the value is 86.32. This value is within the healthy range. It has increased from 70.61 (Mar 24) to 86.32, marking an increase of 15.71.
- For Return on Capital Employeed (%), as of Mar 25, the value is 111.06. This value is within the healthy range. It has increased from 92.26 (Mar 24) to 111.06, marking an increase of 18.80.
- For Return On Assets (%), as of Mar 25, the value is 47.59. This value is within the healthy range. It has increased from 41.40 (Mar 24) to 47.59, marking an increase of 6.19.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.94. It has increased from 1.87 (Mar 24) to 1.94, marking an increase of 0.07.
- For Current Ratio (X), as of Mar 25, the value is 1.38. This value is below the healthy minimum of 1.5. It has decreased from 1.54 (Mar 24) to 1.38, marking a decrease of 0.16.
- For Quick Ratio (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has decreased from 1.30 (Mar 24) to 1.08, marking a decrease of 0.22.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.69. This value is within the healthy range. It has increased from 4.61 (Mar 24) to 4.69, marking an increase of 0.08.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 113.57. This value exceeds the healthy maximum of 50. It has increased from 88.35 (Mar 24) to 113.57, marking an increase of 25.22.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 102.02. This value exceeds the healthy maximum of 50. It has increased from 78.22 (Mar 24) to 102.02, marking an increase of 23.80.
- For Earning Retention Ratio (%), as of Mar 25, the value is -13.57. This value is below the healthy minimum of 40. It has decreased from 11.65 (Mar 24) to -13.57, marking a decrease of 25.22.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is -2.02. This value is below the healthy minimum of 40. It has decreased from 21.78 (Mar 24) to -2.02, marking a decrease of 23.80.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 485.39. This value is within the healthy range. It has increased from 395.76 (Mar 24) to 485.39, marking an increase of 89.63.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 333.59. This value is within the healthy range. It has increased from 269.83 (Mar 24) to 333.59, marking an increase of 63.76.
- For Enterprise Value (Cr.), as of Mar 25, the value is 63,942.79. It has decreased from 72,358.90 (Mar 24) to 63,942.79, marking a decrease of 8,416.11.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 10.59. This value exceeds the healthy maximum of 3. It has decreased from 12.74 (Mar 24) to 10.59, marking a decrease of 2.15.
- For EV / EBITDA (X), as of Mar 25, the value is 30.49. This value exceeds the healthy maximum of 15. It has decreased from 36.59 (Mar 24) to 30.49, marking a decrease of 6.10.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 10.77. This value exceeds the healthy maximum of 3. It has decreased from 12.98 (Mar 24) to 10.77, marking a decrease of 2.21.
- For Retention Ratios (%), as of Mar 25, the value is -13.57. This value is below the healthy minimum of 30. It has decreased from 11.64 (Mar 24) to -13.57, marking a decrease of 25.21.
- For Price / BV (X), as of Mar 25, the value is 39.07. This value exceeds the healthy maximum of 3. It has decreased from 39.34 (Mar 24) to 39.07, marking a decrease of 0.27.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 10.77. This value exceeds the healthy maximum of 3. It has decreased from 12.98 (Mar 24) to 10.77, marking a decrease of 2.21.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Colgate-Palmolive (India) Ltd:
- Net Profit Margin: 23.78%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 111.06% (Industry Average ROCE: 29.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 86.32% (Industry Average ROE: 23.91%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 333.59
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.08
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 44.8 (Industry average Stock P/E: 56.6)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 23.78%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Personal Care | Colgate Research Centre, Main Street, Mumbai Maharashtra 400076 | investors_grievance@colpal.com http://www.colgatepalmolive.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Mukul Deoras | Chairman |
| Ms. Prabha Narasimhan | Managing Director & CEO |
| Mr. M S Jacob | WholeTime Director & CFO |
| Mr. Surender Sharma | Whole Time Director |
| Mr. Sekhar Natarajan | Ind. Non-Executive Director |
| Ms. Sukanya Kripalu | Ind. Non-Executive Director |
| Ms. Gopika Pant | Ind. Non-Executive Director |
| Dr. Indu Bhushan | Ind. Non-Executive Director |
| Mr. Sanjay Gupta | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Colgate-Palmolive (India) Ltd?
Colgate-Palmolive (India) Ltd's intrinsic value (as of 27 November 2025) is 1733.54 which is 20.73% lower the current market price of 2,187.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 59,483 Cr. market cap, FY2025-2026 high/low of 3,115/2,148, reserves of ₹1,555 Cr, and liabilities of 3,178 Cr.
What is the Market Cap of Colgate-Palmolive (India) Ltd?
The Market Cap of Colgate-Palmolive (India) Ltd is 59,483 Cr..
What is the current Stock Price of Colgate-Palmolive (India) Ltd as on 27 November 2025?
The current stock price of Colgate-Palmolive (India) Ltd as on 27 November 2025 is 2,187.
What is the High / Low of Colgate-Palmolive (India) Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Colgate-Palmolive (India) Ltd stocks is 3,115/2,148.
What is the Stock P/E of Colgate-Palmolive (India) Ltd?
The Stock P/E of Colgate-Palmolive (India) Ltd is 44.8.
What is the Book Value of Colgate-Palmolive (India) Ltd?
The Book Value of Colgate-Palmolive (India) Ltd is 58.2.
What is the Dividend Yield of Colgate-Palmolive (India) Ltd?
The Dividend Yield of Colgate-Palmolive (India) Ltd is 2.35 %.
What is the ROCE of Colgate-Palmolive (India) Ltd?
The ROCE of Colgate-Palmolive (India) Ltd is 105 %.
What is the ROE of Colgate-Palmolive (India) Ltd?
The ROE of Colgate-Palmolive (India) Ltd is 81.2 %.
What is the Face Value of Colgate-Palmolive (India) Ltd?
The Face Value of Colgate-Palmolive (India) Ltd is 1.00.